London (Reuters Health) – AstraZeneca said that he chose
Leif Johansson to lead your directory at a time in
that the pharmaceutical company faces the challenge of a
reduction of income, cuts in employment and review of
drugs in phase of development after a series of setbacks.
Johansson has been President of the leading manufacturer of
from April 2011 and before Ericsson mobile telephony equipment
that was the Executive President of the second manufacturer of the
world of trucks, Volvo AB.
Was also Executive President of the manufacturer of
director and Electrolux home appliances not
Executive of Bristol-Myers Squibb from 1998 to 2011.
AstraZeneca is facing in the next five years to the
loss of exclusivity of many of their medications from
biggest sale and has few alternatives for development.
Anglo-suizo manufacturer is cutting other 7,300
jobs and expected that earnings will fall this year
between 14 and 18 per cent, as they win patents
of key medicines and Governments in Europe and
United States are pushing prices.
AstraZeneca said that Johansson would be proposed as director
non-executive of the company at the annual meeting of shareholders
on April 26, in order to designate it company
as from September 1, non-Executive Chairman when
withdrawal of the current owner Louis Schwitzer.
